— Know what they know.
Not Investment Advice

PTKFY OTC

PT Kalbe Farma Tbk
1W: +4.4% 1M: -1.6% 3M: -1.5% YTD: -40.3% 1Y: -42.4% 3Y: -69.1% 5Y: -55.4%
$8.56
+0.46 (+5.68%)
 
Weekly Expected Move ±9.2%
$7 $8 $9 $9 $10
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 42 · $9.7M mcap · 451879 float · 0.202% daily turnover · Short 70% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$9.7M
52W Range7.63-16.36
Volume68
Avg Volume911
Beta0.05
Dividend$0.22
Analyst Ratings
No analyst coverage
Company Info
CEOBernadette Ruth Irawati Setiady
Employees12,835
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2012-08-13
Gedung KALBE
Jakarta, JK 10510
ID
62 21 4287 3888
About PT Kalbe Farma Tbk

PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health division includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals division sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic division maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms